Effects of Nichi BRITE β-glucans as an onco-nutrition adjuvant in patients undergoing subtotal stomach-preserving pancreaticoduodenectomy (SSPPD) for pancreatic, bile duct and duodenal malignancies: A clinical study
Administration of Nichi BRITE β-glucan during the perioperative period in patients undergoing surgery for pancreatic, bile duct and duodenal malignancies has been safe, and it has yielded immune enhancement and improvement in biomarkers of better prognosis. Reduction in circulating cancer stem cells and pancreatic cancer marker CA19-9 inclines us to recommend this Nichi BRITE β-glucan be included in onco-nutrition guidelines for patients undergoing surgical removal of malignant tumors.
Authors
- Samuel JK Abraham (ORCID: https://orcid.org/0000-0003-2646-2687)
- Koji Ichiyama
- Nobunao Ikewaki
- Satomi Uchiyama
- Akira Tsukada
- Rajappa Senthilkumar (ORCID: https://orcid.org/0000-0002-9568-7639)
- Daiki Tabe
- Masaru Iwasaki (ORCID: https://orcid.org/0000-0003-3766-8744)
- Isao Miyajima
Institutions
- Kyushu University of Health and Welfare (JP)
- Chikamori Hospital (JP)
- University of Yamanashi (JP)
Publication Details
- Journal
- Nutrition
- Published
- 2025-04-18
- DOI
- https://doi.org/10.1016/j.nut.2025.112811
- Citations
- 2
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 2.09